Announcement on Resignation of Independent Director
Filed with SSE · · 2 pages · Chinese
Shanghai OPM Biosciences Co., Ltd. on 6ix
Earlier from Shanghai OPM Biosciences
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Indicative Announcement on Reply to Regulatory Inquiry Regarding the Issuance of Shares and Cash Payment for Asset Acquisition with Supporting Fund-raising (Revised Draft)
- Announcement on Approval by the Shanghai Stock Exchange M&A and Restructuring Review Committee for the Company's Issuance of Shares and Cash Payment to Purchase Assets and Raise Supporting Funds
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on the Draft Revision of the Report (Draft) (Revised Edition) on Issuing Shares, Paying Cash for Asset Acquisition, Raising Supporting Funds
Later from Shanghai OPM Biosciences
- Announcement on Progress in Participating in the Establishment of Industrial Funds
- Announcement on Resolutions of the 18th Meeting of the 2nd Board of Directors
- Announcement on Voluntary Disclosure of the Company and Wholly-owned Subsidiary Certified as High-tech Enterprises
- Announcement on Completing Transfer of Underlying Assets Related to the Company's Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Shanghai OPM Biosciences into a list and get an email when it puts out news.
Follow Shanghai OPM Biosciences